fbpx

ExpreS2ion Biotechnologies – Presentation of Year-End report 2021

ExpreS2ion Biotechnologies – Presentation of Year-End report 2021 24 FebruarFeb 2022 11:30 - 12:00 Europe/Copenhagen

ExpreS2ion Biotechnologies – Presentation of Year-End report 2021

Watch our live event where CEO of ExpreS2ion Biotechnologies, Bent Frandsen, and CFO, Keith Alexander present the Year-end report financial results. During the event, it will be possible to ask questions.

Outside the financial result, there will also be a focus on the positive pipeline topline results for its HER2-cVLP breast cancer vaccine announced both in December and January.

ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines. Currently the company is developing vaccines against Covid-19, breast cancer and Influenza.

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR / Corporate Visibility subscription agreement.

Deltag her

Du vil blive videresendt til en ekstern tilmeldingsside. 

Information

ExpreS2ion Biotechnologies – Presentation of Year-End report 2021 24 FebruarFeb 2022 11:30 - 12:00 Europe/Copenhagen
ExpreS2ion Biotechnologies – Presentation of Year-End report 2021
ExpreS2ion Biotechnologies